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Abstract Adrenodoxin reductase is an essential component of
the mitochondrial monooxygenase systems that are involved in
the synthesis of steroid hormones and related compounds. After
removing by mutagenesis a secondary ribosome binding site and
an mRNA loop formed between the gene and the vector, large
amounts of the enzyme could be produced in Escherichia coli by
coexpression with the HSP60-chaperone system. The purified
protein was homogeneous enough for reproducible crystalliza-
tion. The crystals diffracted X-rays isotropically beyond 1.7 Aî
resolution permitting a structure analysis.
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1. Introduction
Adrenodoxin reductase (adrenal ferredoxin-NADPH oxi-
doreductase, AdR, EC 1.18.1.2) is an FAD-containing enzyme
that represents the ¢rst component in the mitochondrial P450
electron transfer systems [1,2]. AdR receives two electrons
from NADPH and transfers them one at a time to adreno-
doxin, which then transports them to the P450 cytochromes.
All proteins of these P450 systems are located at the matrix
side of the inner mitochondrial membrane.
AdR is encoded by one nuclear gene and is expressed in all
human tissues that have been examined [3]. The AdR-adreno-
doxin couple provides the electrons for at least six di¡erent
mitochondrial P450 cytochromes that are expressed in a tis-
sue-speci¢c manner. The reactions catalyzed by these P450
systems include cholesterol side chain cleavage, steroid 11L-
and 18-hydroxylations, sterol C27-hydroxylation and vitamin
D3 1K- and 25-hydroxylations which represent crucial steps in
the biosynthesis of steroid hormones, bile acids and active
vitamin D derivatives.
To elucidate the enzyme mechanism in detail, bovine [4^6]
and porcine AdR [7] have been crystallized. Further crystals
were obtained from bovine AdR cross-linked with adrenodox-
in [8], the structure of adrenodoxin is known [9]. All AdR
crystals were apparently not adequate for detailed analysis.
Therefore, we undertook to improve AdR production by ex-
pression in Escherichia coli. Unfortunately, E. coli shows a
tendency, especially for eukaryotic proteins like AdR, to ex-
press the synthesized peptide in inclusion bodies [10]. The
amount of correctly folded protein, however, can be increased
by coexpression of chaperones [11,12]. Here, we report a high-
yield expression system with subsequent puri¢cation that re-
sulted in readily growing X-ray-grade crystals of authentic
AdR.
2. Materials and methods
2.1. AdR isolation from bovine adrenal cortex
AdR was puri¢ed as described [13]. In brief, 1.0 kg adrenal cortex
was obtained from about 100 adrenals. The mitochondria were iso-
lated and sonicated. An AdR-enriched fraction was isolated by am-
monium sulfate precipitation, dialyzed against 10 mM KH2PO4,
0.04 mM EDTA and loaded onto a DE52 ion exchange column
(Whatman), from which it was then eluted with 50 mM KH2PO4,
0.04 mM EDTA and dialyzed against 10 mM KH2PO4. AdR was
then loaded onto an adrenodoxin-Sepharose a⁄nity column, washed
with 40 mM KCl, 10 mM KH2PO4 and eluted with 240 mM KCl,
10 mM KH2PO4. All handling was at pH 7.35 and 4‡C.
2.2. Mutagenesis and expression vectors
The cDNA of AdR was transferred from vector pBAR1607 [14]
into vector pET22b (Novagen). Using PCR [15] with the N-terminal
primer 5P-TTATCCATGGCAAGCACTCAAGAACAAACCCC-3P
and the C-terminal primer 5P-GTATCAAGCTTCTAGGCTCAGTG-
TCCCAGCAG-3P, the cDNA was ampli¢ed and restriction sites were
introduced. For mutagenesis we applied the mega-primer method [16].
The primers for the destruction of the secondary ribosome binding
site and for the removal the mRNA loop were 5P-TCGCCCGCGC-
AAACGGCTGATGGAACTG-3P and 5P-CCTCTAGAAATATTTT-
TGTTTAAAATTAAGAAGG-3P, respectively. PCR was performed
with Pfu polymerase (Stratagene). DNA was sequenced on a blotter
(GATC-1500) using Thermo Sequenase (Amersham). For coexpres-
sion with chaperones we transformed [17] E. coli BL21(DE3) harbor-
ing the AdR-encoding plasmid pET22b3-AR242 (ampicillin resist-
ance) with either the HSP60 or the HSP70 system containing
expression vectors pREP4-groESL or pRDKJG, respectively (P. Cas-
pers, Ho¡mann-La Roche). Both vectors possess kanamycin resist-
ance.
2.3. AdR expression and puri¢cation
E. coli BL21(DE3) harboring plasmids pET22b3-AR242 and
pREP4-groESL were grown at 37‡C in 8U250 ml LB medium with
100 Wg/ml ampicillin and 25 Wg/ml kanamycin. At an OD578 of 0.6 the
temperature was lowered to 20‡C, the cells were induced with 1 mM
IPTG, further cultivated for about 15 h and harvested by centrifuga-
tion. All subsequent handling was at 4‡C. The pellet was suspended in
30 ml 10 mM KH2PO4 pH 7.4, 1 mM EDTA (bu¡er P) with 1 mM
PMSF and sonicated. The cell suspension was centrifuged (60 min at
47 000Ug) and the cytosol was dialyzed overnight against bu¡er P at
pH 8.0. The protein solution was diluted with bu¡er P to 300 ml and
run through an ion exchange column (Source Q, Pharmacia), which
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was further washed with 200 ml bu¡er P. The £ow-through was
loaded onto a 2P,5P-ADP-Sepharose column (Pharmacia), washed,
and eluted with a 0^400 mM NaCl gradient in bu¡er P.
2.4. Crystallization and X-ray di¡raction
The protein was concentrated to 10 mg/ml (Centriprep, Millipore)
and dialyzed against 50 mM sodium cacodylate pH 6.5, 100 mM
calcium acetate (bu¡er C). For crystallization we applied vapor dif-
fusion using the hanging drop method. The 10 Wl droplets contained
4 mg/ml AdR in bu¡er C with 8% (w/v) PEG 8000. The reservoir
consisted of bu¡er C with 12% (w/v) PEG 8000. For data collection at
cryo temperature, the crystals were stepwise transferred into reservoir
bu¡er with 20% glycerol.
X-ray di¡raction data were collected on a multiwire detector (Sie-
mens, model X-1000) attached to a rotating anode generator (Rigaku,
model RU200B). The data were processed with program XDS [18].
Synchrotron data were collected at beamline X11 at EMBL/DESY-
Hamburg using an image plate (MARresearch, model 30-cm) and
processed with MOSFLM [19]. All data were scaled and reduced
using programs SCALA and TRUNCATE [20].
3. Results and discussion
3.1. Isolation and crystallization of native AdR
At ¢rst AdR, a monomeric enzyme with an Mr of 51 079,
was prepared from bovine adrenal cortex. This expensive and
tedious procedure [13] yielded about 20 mg AdR per kg adre-
nal cortex obtained from more than 100 animals. Crystalliza-
tion conditions were established by screening [21] and then
re¢ned. The resulting crystals were named form A, they dif-
fracted to 2.6 Aî resolution. A data set based on a unit cell
with presumably one molecule per asymmetric unit was col-
lected at room temperature and processed (Table 1). Subse-
quent analyses revealed a superstructure indicated by weak
additional re£ections. The relationship between the small, ap-
parent unit cell and the four times larger proper unit cell is
shown in Fig. 1.
3.2. AdR expression in E. coli
Because of crystal shortage, we changed to recombinant
AdR, following Sagara et al. [14] who reported functional
expression of AdR with a yield of 2.5 mg/l culture. Several
attempts to reproduce the described procedure, however, re-
sulted in AdR expression into inclusion bodies (Fig. 2, lanes 2
and 3). We therefore transferred the AdR cDNA from vector
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Table 1
Crystal statistics and X-ray di¡raction
Crystal form A A AP AQ
Temperature (K) 300 300 100 100
Glycerol (%) ^ ^ 20 20
Space group P21 P21 P21 P21
Unit cell
a (Aî ) 60.3a 85.5 60.8 57.8
b (Aî ) 63.1 63.0 62.5 62.0
c (Aî ) 81.2 220.4 78.4 83.0
L (‡) 107.2 95.3 106.8 107.1
VM (Aî 3/Da) 2.9b 2.9c 2.8b 2.8b
Di¡raction limit (Aî ) 2.6d 3.2 1.7d 2.3
Observations 76 890 69 695 268 079 58 709
Unique re£ections 16 710 33 096 56 738 20 372
Completeness (%) 92 85 93 74
Rsym (%) 10.9 15.7 4.9 4.8
aData were collected and processed ignoring the low intensity superstructure (Fig. 1).
bAssuming one AdR molecule in the asymmetric unit.
cAssuming four AdR molecules in the asymmetric unit.
dData were collected at the beamline X11 at EMBL/DESY Hamburg.
Fig. 1. Sketch of the relationship between the apparent small unit
cell and the real unit cell with superstructure of crystal form A. The
real cell is four times larger than the apparent cell.
Fig. 2. AdR production steps analyzed by SDS-PAGE stained with
Coomassie brilliant blue R250. Lanes 1 and 10, molecular mass
markers; lanes 2 and 3, lysate and cytosolic fraction of induced ex-
pression system pBAR1607/JM109 [14] (arrow at presumed AdR
band); lanes 4 and 5, lysate and cytosolic fraction of expression sys-
tem pET22b3-AR242/BL21(DE3) after induction and addition of
ethanol; lanes 6 and 7, lysate and cytosolic fraction of induced ex-
pression system pET22b3-AR242/pREP4-groESL/BL21(DE3); lane 8,
after ion exchange chromatography; lane 9, puri¢ed AdR.
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pBAR1607 into pET22b (Novagen) and examined the codon
usage in the N-terminal region [22] and for the N-end rule
[23], both of which were obeyed satisfactorily. We then
checked for secondary E. coli ribosome binding sites in the
AdR cDNA [24], found one and removed it by three silent
point mutations (Fig. 3). A search for stable secondary
mRNA structures near the Shine-Dalgarno sequence [25] re-
vealed one putative loop formed between the cDNA of AdR
and the vector with vG37 =38.9 kcal/mol. We destabilized
this loop by three silent point mutations (Fig. 3). After these
changes, the expression rate increased appreciably, but AdR
was still expressed into inclusion bodies.
Since AdR is imported into mitochondria where it is folded
with the help of chaperones, we subsequently enhanced the
amount of chaperones in E. coli by the addition of ethanol to
the medium after induction [26]. This increased the amount of
soluble AdR (Fig. 2, lanes 4 and 5), though not to a su⁄-
ciently high level. Therefore we changed to direct chaperone
expression by additional vectors [27]. We transformed either
the HSP60 or the HSP70 system in a bacterial strain harbor-
ing the modi¢ed AdR-encoding plasmid pET22b3-AR242.
This did not change the overall amount of AdR, but especially
the HSP60 system increased the fraction of soluble, folded
AdR (Fig. 2, lanes 6 and 7). AdR was isolated by ion ex-
change chromatography followed by an 2P,5P-ADP-Sepharose
column (Fig. 2, lanes 8 and 9), yielding about 10 mg/l culture
(4 mg/l for HSP-70). The protein bound to an adrenodoxin-
Sepharose column (Section 2.1) indicating that it assumed its
native conformation.
3.3. Crystals and X-ray data collection
The recombinant enzyme, crystallized under the same con-
ditions as the native enzyme, yielding crystal form A with the
same superstructure (Fig. 1). This is a further strong indica-
tion that the recombinant enzyme is authentic and in its native
conformation. For X-ray di¡raction measurements at a cryo
temperature of 100 K, we transferred the crystals successively
from the crystallization droplet into reservoir bu¡er contain-
ing 5, 10, 15 and 20% glycerol. During this procedure the
crystals developed small cracks, but remained intact even after
shock-freezing. X-ray analyses revealed that glycerol had
changed the molecular packing scheme at 300 K as well as
100 K, giving rise to unit cell parameters similar to those of
the apparent (small) unit cell of crystal from A. The super-
structure had disappeared. This highly ordered crystal form
was named AP (Table 1). It could be produced directly by
adding 5% glycerol to the usual crystallization set-ups, and
it could be transferred to 20% glycerol without developing
cracks. A data set was collected (Table 1). In one crystalliza-
tion drop we obtained a further related crystal form AQ (Table
1). In conclusion, the high-yield expression system provided us
with enough homogeneous material for determining the struc-
ture in order to understand the enzyme mechanism.
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Fig. 3. Optimized expression vector pET22b3-AR242 encoding bo-
vine AdR (mutations are shown as bold, underlined).
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